Chiasma, Inc. (CHMA) |
| 3.76 -0.24 (-6%) 04-24 15:47 |
| Open: | 4.08 |
| High: | 4.1 |
| Low: | 3.76 |
| Volume: | 8,196,718 |
| Market Cap: | 0(M) |
| PE Ratio: | -2.39 |
| Exchange: | NASDAQ Global Select |
| Industry: | Biotechnology |
| Sector: | Healthcare |
| Technical analysis | ||||
 |
||||
| sell | buy | |||
| Resistance 2: | 12.07 |
| Resistance 1: | 10.33 |
| Pivot price: | 10.29 |
| Support 1: | 10.27 |
| Support 2: | 10.24 |
| 52w High: | 5.74 |
| 52w Low: | 2.77 |
Chiasma, Inc. is a biopharmaceutical company in the advanced stages of clinical development, specializing in oral drug formulations. The company utilizes its Transient Permeability Enhancer (TPE) technology platform to develop treatments for rare and serious chronic conditions on a global scale. A key product in its pipeline is MYCAPSSA, an oral octreotide capsule currently in Phase III clinical trials. MYCAPSSA is intended for adult patients diagnosed with acromegaly, a disorder marked by the overproduction of growth hormone in the body. Founded in 2001, Chiasma, Inc. is headquartered in Needham, Massachusetts.
Financials
| EPS | 0.000 |
| Book Value | -0.390 |
| PEG Ratio | 0.00 |
| Gross Profit | 0.000 |
| Profit Margin (%) | 0.00 |
| Operating Margin (%) | 0.00 |
| Return on Assets (ttm) | 0.0 |
| Return on Equity (ttm) | 0.0 |
Company news
Wed, 14 Dec 2022
Chaime Orlev Net Worth (2026) - GuruFocus
Tue, 27 Jul 2021
Pulmatrix Appoints Director Anand Varadan - citybiz
Wed, 05 May 2021
Amryt Pharma to Acquire Chiasma, Inc. to Further Strengthen Global Leadership in Rare and Orphan Diseases - GlobeNewswire
Mon, 11 Apr 2016
Weekly Biotech Report covering – Opko Health Inc (NYSE:OPK) Intercept Pharmaceuticals (NASDAQ:ICPT) Gilead Sciences, Inc (NASDAQ:GILD) Clovis Oncology, Inc. (NASDAQ:CLVS) Chiasma, Inc. (NASDAQ:CHMA) - marketexclusive.com
Sun, 19 Jul 2015
5 IPOs Due to Launch in the Week of July 20 - 24/7 Wall St.
Tue, 14 Jul 2026
 StockChart iOS |
 StoxlineLite iOS |
StoxlineLite iOS |
 OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |
